108 related articles for article (PubMed ID: 32483123)
1. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation.
Wang SQ; Liu J; Qin J; Zhu Y; Tin VP; Yam JWP; Wong MP; Xiao ZJ
Cell Death Dis; 2020 Jun; 11(6):410. PubMed ID: 32483123
[TBL] [Abstract][Full Text] [Related]
2. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma.
Xiao ZJ; Liu J; Wang SQ; Zhu Y; Gao XY; Tin VP; Qin J; Wang JW; Wong MP
Elife; 2017 Jul; 6():. PubMed ID: 28737489
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA
Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
[TBL] [Abstract][Full Text] [Related]
4. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
Ooki A; Dinalankara W; Marchionni L; Tsay JJ; Goparaju C; Maleki Z; Rom WN; Pass HI; Hoque MO
Oncogene; 2018 Nov; 37(45):5967-5981. PubMed ID: 29980786
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
[TBL] [Abstract][Full Text] [Related]
7. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.
Bora-Singhal N; Mohankumar D; Saha B; Colin CM; Lee JY; Martin MW; Zheng X; Coppola D; Chellappan S
Sci Rep; 2020 Mar; 10(1):4722. PubMed ID: 32170113
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated epigenetic suppression of SH3BGRL potently inhibits lung cancer progression.
Liu Z; Xu W; Tan X; Li C
Biochem Biophys Res Commun; 2021 Apr; 548():53-59. PubMed ID: 33631674
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
10. LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition.
Fu X; Lin J; Qin F; Yang Z; Ding Y; Zhang Y; Han L; Zhu X; Zhang Q
Mol Carcinog; 2018 Mar; 57(3):408-418. PubMed ID: 29144570
[TBL] [Abstract][Full Text] [Related]
11. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
12. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
[TBL] [Abstract][Full Text] [Related]
14. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
15. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer Dissemination.
Kuo MH; Lee AC; Hsiao SH; Lin SE; Chiu YF; Yang LH; Yu CC; Chiou SH; Huang HN; Ko JC; Chou YT
Cancer Res; 2020 Oct; 80(20):4426-4438. PubMed ID: 32816907
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
[TBL] [Abstract][Full Text] [Related]
19. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
20. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
Lee YY; Mok MT; Kang W; Yang W; Tang W; Wu F; Xu L; Yan M; Yu Z; Lee SD; Tong JHM; Cheung YS; Lai PBS; Yu DY; Wang Q; Wong GLH; Chan AM; Yip KY; To KF; Cheng ASL
Nucleic Acids Res; 2018 Sep; 46(17):8832-8847. PubMed ID: 29992318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
